Preview Citation


Burtness, B., Anadkat, M., Basti, S., Hughes, M., Lacouture, M. E., McClure, J. S., Myskowski, P. L., Paul, J., Perlis, C. S., Saltz, L., & Spencer, S. (2009). NCCN Task Force Report: Management of Dermatologic and Other Toxicities Associated With EGFR Inhibition in Patients With Cancer, Journal of the National Comprehensive Cancer Network J Natl Compr Canc Netw, 7(Suppl_1), S-5-S-21. Retrieved Apr 3, 2020, from